Nasal NK/T-cell lymphoma: Epidemiology and pathogenesis

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 110-117

  Aozasa, Katsuyuki ^a   Takakuwa, Tetsuya ^a   Hongyo, Tadashi ^a   Yang, Woo Ick ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

c KIT gene; Epidemiology; Epstein Barr virus; Nasal lymphoma; NK T cell type; p53 gene; Pesticide

Indexed keywords

FAS ANTIGEN; PESTICIDE; PROTEIN P53; SOLVENT; STEM CELL FACTOR RECEPTOR;

DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENE FREQUENCY; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IN SITU HYBRIDIZATION; KOREA; LIFESTYLE; MORBIDITY; MUTATION; NATURAL KILLER T CELL; NOSE TUMOR; ONCOGENE; PATHOGENESIS; REVIEW; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

ASIA; ENVIRONMENTAL EXPOSURE; EPSTEIN-BARR VIRUS INFECTIONS; GENES, P53; HUMANS; KILLER CELLS, NATURAL; LATIN AMERICA; LYMPHOMA, T-CELL; NOSE NEOPLASMS; PESTICIDE RESIDUES; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 42149083796     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0021-7     Document Type: Review

References (75)

1. McBride P. Photographs of a case of rapid destruction of the nose & face. Laryngol. 1987;12:64-6.
2. Eichel BS, Harrison EGJ, Devine KD, Scanlon PW, Brown HA. Primary lymphoma of the nose including relationship to lethal midline graanuloma. Am J Surg. 1966;112:597-605.
3. Kassel S, Echevaria RA, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer. 1969;23:920-35.
4. Godman GC, Churg J. Wegener's granulomatosis, pathology and review of the literature. Arch Pathol. 1954;58:533-53.
5. Ishii Y, Yamanaka N, Ogawa K, Yoshida Y, Takami T, Matsuura A, et al. Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma". Cancer. 1982;50:2336-44.
6. Chan KC, Ng CS, Lau WH, Lo ST. Most nasal/ nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 1987;11:418-29.
7. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J. Absence of clonal beta and gamma T-cell receptor gene rarrangements in a subset of peripheral T-cell lymphomas. Am J Pathol. 1988;130:436-42.
8. Ng CS, Chan JKC, Lo STH. Expression of natural-killer-cell markers in non-Hodgkin's lymphomas. Hum Pathol. 1987;18:1257-62.
9. + phenotype. Cancer. 1995;75:894-901.
10. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466-73.
11. Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255-60.
12. Ohsawa M, Nakatsuka S, Kanno H, Miwa H, Kojya S, Harabuchi Y, et al. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. Int J Cancer. 1999;81:865-70.
13. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics of Tumors of Haemapoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001.
14. Kluin PM, Feller A, Gaulard P, Jaffe ES, Meijer CJLM, Muller-Hermelink HK, et al. Peripheral T/NK-cell lymphoma: a report of IXth workshop of the European Association for Hematopathology. Histopathology. 2001;38:250-70.
15. Ng SB, Lai KW, Murugana S, Lee KM, Loong SL, Fook-Chong S, et al. Nasal type extranodal natural killer/T-cell lymphomas; A clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17:1097-107.
16. Chan JKC, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, et al. Nonnasal lymphomas expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of uncommon aggressive neoplasm. Blood. 1997;89:4501-13.
17. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335:128-30.
18. Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688-95.
19. Mishima K, Horiuchi K, Kojya S, Takahashi H, Ohsawa M, Aozasa K. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer. 1994;73:3041-6.
20. Chan JKC,Yip TTC, Tsang WYW, Ng CS, Lau WH, Poon YF, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol. 1994;18:938-46.
21. Tomita Y, Ohsawa M, Mishiro Y, Kubo T, Maeshiro S, Kojya S, et al. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest. 1995;73:190-6.
22. + immunophenotype and polymorphic reticulosis morphology. Int J Cancer. 1997;70:9-13.
23. Hardjolukito E, Kurniawan AN, Kodairiah R, Ham MF, Luo WJ, Nakatsuka S, et al. Sinonasal lymphomas in Indonesia; Immunophenotype and Epstein-Barr virus association. Med J Indonesia. 2004;13:71-6.
24. Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx : clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-7.
25. Dambaugh T, Hennessy K, Chamnankit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr virus nuclear antigen 2. Proc Natl Acad Sci USA. 1984;81:7632-6.
26. Chen X, Pepper S, De V, Arrand JR. Prevalence of A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from South China. J Gen Virol. 1992;73:463-6.
27. Peh SC, Sardves K, Pallesen G. Epstein-Barr virus (EBV) in Malaysian upper-aerodigestive-tract lymphoma: incidence and subtype. Int J Cancer. 1995;61:327-32.
28. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated lymphohma. Blood. 1991;78:3004-11.
29. Borisch B, Henning I, Laeng RH, Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood. 1993;82:858-64.
30. Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv. 1992;13:53-80.
31. Shen L, Chiang AK, Liu WP, Li GD, Liang RH, Srivastava G. Expression of HLA class I, beta(2)-microglobulin, TAP 1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: implications for tumor immune escape mechanism. Int J Cancer. 2001;92:692-6.
32. Yong L, Alfieri C, Hennessy K, Evans H, Ohara C, Anderson KC, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative diseases. N Engl J Med. 1989; 321:1080-5.
33. Chiang AK, Tao Q, Srivastava G, Ho FC. Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer. 1996;68:285-90.
34. Chiang AK, Wong KY, Liang AC, Srivastava G. Comparative analysis of Epstein-Barr virus gene polymorphism in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int J Cancer. 1999;80:356-64.
35. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Ann Rev Immunol. 1997;15:405-31.
36. Khanna R, Burrows SR, Nicholls J, Poulsen LM. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 subtype restricted immune recognition of EBV-infected cells by LMP1-specific cytoxic T lymphocytes. Eur J Immunol. 1998;28:451-8.
37. Kanno H, Kojya S, Li T, Ohsawa M, Nakatsuka S, Miyaguchi M, et al. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reiculosis morphology. Int J Cancer. 2000;87:195-9.
38. Li T, Hongyo T, Syaifudin M, Nomura T, Dong Z, Shingu N, et al. Mutations of the p53 gene in nasal NK/T-cell lymphoma. Lab Invest. 2000;80:493-9.
39. Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y, et al. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res. 2000;60:2345-7.
40. Hoshida Y, Hongyo T, Jia XS, He Y, Hasui K, Dong Z, et al. Analysis of p53, k-ras, c-kit, and β-catenin gene mutatuins in sinonasal NK/T cell lymphoma in northeast district of China. Cancer Sci. 2003;94:297-301.
41. Hongyo T, Hoshida T, Nakatsuka S, Syaifudin M, Kojya S, Yang WI, et al. p53, k-ras, and β-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan. Oncol Rep. 2005;13:267-71.
42. Kurniawan AN, Hongyo T, Hardjolukito ESR, Ham MF, Takakuwa T, Kodairiah R, et al. Gene mutation analysis of sinonasal lymphoma in Indonesia. Oncol Rep. 2006;15:1257-63.
43. Quintanilla-Martinez L, Kremer M, Keller G, Nathrath M, Gamboa-Dominguez A, Meneses A, et al. p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large ccell morphology and advanced disease. Am J Pathol. 2001;159:2095-105.
44. Levine AJ, Momand J, Finley CA. The p53 tumor suppressor gene. Nature. 1991;351:453-6.
45. Hollstein M, Sidransky D, Vogelstein B, Harris SR. p53 mutation in human cancers. Science. 1991;253:49-53.
46. Greenblatt MS, Benett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-78.
47. Takakuwa T, Li T, Kanno H, Nakatsuka S, Aozasa K. No evidence of replication error phenotype in nasal NK/T-cell lymphoma. Int J Cancer. 1999;84:623.
48. Quintanilla-Martinez L, Franklin JL, Guerrero J, Krenacs L, Naresh KN, Rama-Rao C, et al. Histological and immunophenotypic profile of nasal NK/T-cell lymphomas from Peru: higher prevalence of p53 overexpression. Hum Pathol. 1999;30:849-55.
49. Williams DE, de Vries P, Namen AE, Widmer MB, Lyman SD. The steel factor. Dev Biol. 1992;151:368-76.
50. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda K, Ishikawa J, et al. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood. 1996;88:995-1004.
51. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169-78.
52. Gronbaek K, Straten PT, Ralfkier E, Ahrenkiel V, Andersen MK, Hansen NE, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood. 1998;92:3018-24.
53. Shen L, Liang ACT, Lu L, Au WY, Kwong YL, Liang RHS, et al. Frequent delection of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma. Am J Pathol. 2002;161:2123-31.
54. Takakuwa T, Dong Z, Nakatsuka S, Kojya S, Harabuchi Y, Yang Wl, et al. Frequent mutation of Fas gene in nasal NK/T cell lymphoma. Oncogene. 2002;21:4702-5.
55. Sun HS, Su IJ, Lin YC, Chen JS, Fang SY. A 2.6Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma. Br J Hematol. 2003;122:590-9.
56. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period. Int J Cancer. 1984;34:143-8.
57. Chan JK, Ng CS, Lau WH, Lo STH. Most nasal/ nasopharyngeal lymphomas are peripheral T-cell lymphomas. Am J Surg Pathol. 1987;11:418-29.
58. Ho FC, Choy D, Loke SL, Kung ITM, Fu KH, Liang R, et al. Polymorphic reticulosis and conventional lymphomas of the nose and apper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 1990;21:1041-50.
59. Aozasa K, Watanabe Y, Ikeda H. Malignant histiocytosis presenting as lethal midline granuloma. Path Res Pract. 1981;171:314-24.
60. Aozasa K, Inoue A. Malignant histiocytosis presenting as lethal midline graanuloma: Immunohistological study. J Pathol. 1982;138:241-9.
61. Aozasa K, Ohsawa M, Tajima K, Sasaki R, Maeda H, Matsunaga T, et al. Nation-wide study of lethal midline granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer. 1989;44:63-6.
62. Aozasa K, Yang WI, Lee YB, Pan WS, Wu YF, Horiuchi K, et al. Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer. 1992;52:673-4 (Letter to the Editor).
63. Kojya S, Itokazu T, Maeshiro N, Esu H, Noda Y, Mishima K, et al. Lethal midline granuloma in Okinawa with special emphasis on polymorphic reticulosis. Jpn J Cancer Res. 1994;85:384-8.
64. Gaal K, Sun NCJ, Hernandez AM, Arber DA. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000; 24:1511-7.
65. Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002;13:140-9.
66. Arber DA, Weiss LM, Albujor PF, Chen YY, Jaffe ES. Nasal lymphoma in Peru. High inicidencce of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993;17:392-9.
67. Hardjolukito E, Kurniawan AN, Kodairiah R, Ham MF, Luo WJ, Nakatsuka S, et al. Sinonasal lymphomas in Indonesia: Immunophenotype and Epstein-Barr virus association. Med J Indonesia. 2004;13:71-6.
68. Ohsawa M, Shingu N, Inohara H, Kubo T, Yang WI, Yoon JH, et al. Chronological changes in incidences of polymorphic reticulosis in Korea and Japan. Oncol. 1999;56:202-7.
69. Kojya S, Matsumura J, Li T, Hongvo T, Inazawa J, Kirihata M, et al. Familial nasal NK/T-cell lymphoma and icide use. Am J Hematol. 2001;66:145-7.
70. Zahm SH, Blair A. Pesticides and non-Hodgkin's lymphoma. Cancer Res. 1992;52(Suppl):5485-8.
71. Waterhouse D, Carman WJ, Schottenfeld D, Gridley G, Mclean S. Cancer incidence in the rural community of Tecumseh, Michigan: A pattern of increased lymphopoietic neoplasms. Cancer. 1996;77:763-70.
72. Hardell L, Erickson MA. A case-control study of non-Hodgkin's lymphoma and exposure to pesticide. Cancer. 1999;85:1353-60.
73. Xu JX, Hoshida Y, Yang WI, Inohara H, Kubo T, Kim GW, et al. Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: A case-control study in East Asia. Int J Cancer. 2006;120:406-10.
74. Miligi L, Costantini AS, Bolejack V, Varaldi A, Benvenuti A, Nanni O, et al. Non-Hodgkin's lymphoma, leukemia, and exposure in agriculture: results from the Italian multicenter case-control study. Am J Ind Med. 2003;44:627-36.
75. Chiu BCH, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood. 2006;108:1363-9.